As of Q4'25, TEM reported R&D Expenses of USD 71.9M and SG&A Expenses of USD 208.5M, representing the latest available data points for operating expenses. Both categories have shown significant increases compared to earlier quarters, with SG&A Expenses notably higher than R&D Expenses in this period. Analyzing the trend from Q1'23 to Q4'25, both R&D and SG&A Expenses generally exhibit an upward trajectory, with a pronounced spike in Q2'24 (R&D: USD 146M, SG&A: USD 463.1M) before returning to a steadier growth pattern. This sharp increase in Q2'24 stands out as an anomaly, after which expenses stabilize but continue to rise, particularly for SG&A, which maintains dominance over R&D throughout the period.